TYHT
Undervalued by 33.5% based on the discounted cash flow analysis.
Market cap | $229.17 Million |
---|---|
Enterprise Value | $232.47 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-16.47 |
Beta | 1.85 |
Outstanding Shares | 15,694,600 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.13 |
---|---|
PEG | -0.04 |
Price to Sales | - |
Price to Book Ratio | 11.09 |
Enterprise Value to Revenue | 23.81 |
Enterprise Value to EBIT | -16.8 |
Enterprise Value to Net Income | -6 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.19 |
No data
No data
Shineco, Inc. develops and markets biological health products. The Company focuses on utilizing engineering technologies and biotechnologies to produce Chinese herbal medicines, organic agricultural produce, and specialized textiles.